2005 Annual report - Virbac

More documents

Recommendations

Info

98 Glossary Marketing autorisation: veterinary drugs cannot be marketed without official approval (from the Agriculture Ministry, Health Ministry, Drug Agency, etc.), granted after a dossier is filed, with proof of the product’s efficacy, harmlessness and quality: this is the Marketing autorisation. Endectocide: parasitic drug active both on internal and external parasites. Registration: see marketing autorisation. Electronic identification: animal identification by a tiny subcutaneous implant containing a microchip called a transponder. A specific scanner reads at a distance the unique animal ID number engraved on the transponder. Interferon: a protein with anti-viral properties used in the treatment of certain serious diseases, such as retroviruses or hepatitis. Ivermectin: principal endectocide molecule (active both in internal and external parasites). Lean manufacturing : method which aims to focus on maximising added value for the customer while optimising the resources used. Leishmaniasis: serious disease afflicting dogs and present in Mediterranean countries; transmitted by the sand fly Phlebotomus papaatasi. SANZA : South Africa, New Zealand and Australia.
99 Index Page 5 ◆ Shareholder structure ◆ Animal health market by species ◆ Breakdown of sales Pages 8 and 9 ◆ Change in sales ◆ Change in results ◆ Change in cash flow ◆ Internal growth ◆ Change in investments ◆ Financial structure Page 12 ◆ Share price ◆ Gearing ratios Page 17 ◆ Geographical breakdown of R&D expenditure Animals viewed by Frédéric Decante Frédéric Decante has a passion for animals: a well-known veterinarian and keen photographer, he alternates between, and develops as a result of, both activities. His photographs of companion and food producing animals, which he produces in both black and white and colour and in a wide variety of lay-outs, formats, etc., are so instantaneous that we gain a close understanding of the animals, the work of veterinarians and the links that unite them. His experience and knowledge of the animal world heightens his powers of observation and the accuracy of his photography, resulting in work that is both touching and realistic. His work has captivated Virbac, which has decided to give it considerable exposure in the 2005 edition of its annual report. All the photos on the inside pages were taken by Frédéric Decante. Virbac’s way of paying homage to those who, like Virbac, have a keen interest in animal health. Contact: ff.decante@wanadoo.fr
Page 1 and 2:
2005 Annual report Passionate about
Page 3 and 4:
Bringing our expertise and care to
Page 5 and 6:
1 Contents A message from the Chair
Page 7 and 8:
3 Éric Marée Chairman of the Exec
Page 9 and 10:
5 Breakdown of shareholders in term
Page 11 and 12:
7 In 2005, 30% of sales were genera
Page 13 and 14:
9 Cash flow (in € million) 39.9 2
Page 15 and 16:
11 • A new freeze-dryer with a ca
Page 17 and 18:
13 Finance and stock market Share p
Page 20 and 21:
2005 Annual Report 16 Innovation Mo
Page 22 and 23:
2005 Annual Report 18 The customer
Page 24 and 25:
20 2005 Annual Report The Virbac-Pa
Page 26 and 27:
2005 Annual Report 22 Industrial co
Page 28 and 29:
2005 Annual Report 24 Human resourc
Page 30:
2005 Annual Report 26
Page 33 and 34:
29 Management report 2005 Virbac sa
Page 35 and 36:
31 ❖ Equine Equine products close
Page 37 and 38:
33 ❖ In Portugal 2005 sales at Vi
Page 39 and 40:
35 Acquisitions and disposals Virba
Page 41 and 42:
37 Consolidated balance sheet and f
Page 43 and 44:
39 A resolution will be submitted f
Page 45 and 46:
41 - Member of the Management board
Page 47 and 48:
43 ◆ Investors and analysts are w
Page 49 and 50:
45 ◆ checking air emissions, ◆
Page 51 and 52: 47 Virbac in France Workforce Virba
Page 53 and 54: 49 Report of the Chairwoman of the
Page 55 and 56: 51 financial information, execution
Page 57 and 58: 53 This organisation, put in place
Page 59 and 60: 55 the recognition of transactions
Page 61 and 62: 57 The Industrial operations depart
Page 63 and 64: 59 Consolidated financial statement
Page 69 and 70: 65 Translation of financial stateme
Page 71 and 72: 67 Inventories and work-in-progress
Page 73 and 74: 69 In the case of exchange rate hed
Page 75 and 76: 71 Notes to the consolidated financ
Page 77 and 78: 73 Property, plant and equipment by
Page 79 and 80: 75 Note B7 - Deferred income tax As
Page 81 and 82: 77 Note B12 - Employee benefits (
Page 83 and 84: 79 Note R1 - Sales Sales breakdown
Page 85 and 86: 81 Note R6 - Breakdown of net incom
Page 87 and 88: 83 Note A4 - Composition of Virbac
Page 89 and 90: 85 Note A10 - Consolidation scope a
Page 91 and 92: 87 Transition to IFRS Consolidated
Page 93 and 94: 89 Transition to IFRS LIABILITIES A
Page 95 and 96: 91 Transition to IFRS Breakdown of
Page 97 and 98: 93 Supervisory board report The Exe
Page 99 and 100: 95 As required by law, details of t
Page 101: 97 ❖ to record the finalisation o
Page 105: Virbac 13 ème rue LID - BP 27 0651
show all

2005 Annual report - Virbac

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?